These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10163573)
1. A comparison of the cost effectiveness of alternative prophylactic therapies in childhood asthma. Booth PC; Wells NE; Morrison AK Pharmacoeconomics; 1996 Sep; 10(3):262-8. PubMed ID: 10163573 [TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma. O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013 [TBL] [Abstract][Full Text] [Related]
3. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma. Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218 [TBL] [Abstract][Full Text] [Related]
4. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. Markham A; Jarvis B Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128 [TBL] [Abstract][Full Text] [Related]
5. Fluticasone for the treatment of symptomatic bronchial asthma in children treated with sodium cromogylate--a prospective, randomised trial. von Berg A; Gappa M; Steinkamp G; Eur J Med Res; 2002 Jun; 7(6):257-64. PubMed ID: 12117660 [TBL] [Abstract][Full Text] [Related]
6. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma. Lyseng-Williamson KA; Plosker GL Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627 [TBL] [Abstract][Full Text] [Related]
7. Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma. Lamb HM; Culy CR; Faulds D Pharmacoeconomics; 2000 Nov; 18(5):487-510. PubMed ID: 11151402 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma. Sheth K; Borker R; Emmett A; Rickard K; Dorinsky P Pharmacoeconomics; 2002; 20(13):909-18. PubMed ID: 12381242 [TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children. Barnes NC; Thwaites RM; Price MJ Respir Med; 1999 Jun; 93(6):402-7. PubMed ID: 10464822 [TBL] [Abstract][Full Text] [Related]
10. Development of an economic model to assess the cost effectiveness of asthma management strategies. Price MJ; Briggs AH Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348 [TBL] [Abstract][Full Text] [Related]
11. Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma. Menendez R; Stanford RH; Edwards L; Kalberg C; Rickard K Pharmacoeconomics; 2001; 19(8):865-74. PubMed ID: 11596838 [TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma. Volmer T; Kielhorn A; Weber HH; Wiessmann KJ Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):525-31. PubMed ID: 10662477 [TBL] [Abstract][Full Text] [Related]
13. Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma. Markham A; Adkins JC Pharmacoeconomics; 2000 Dec; 18(6):591-608. PubMed ID: 11227397 [TBL] [Abstract][Full Text] [Related]
14. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma. Price JF; Russell G; Hindmarsh PC; Weller P; Heaf DP; Williams J Pediatr Pulmonol; 1997 Sep; 24(3):178-86. PubMed ID: 9330414 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of fluticasone propionate administered via metered-dose inhaler plus babyhaler spacer in the treatment of asthma in preschool-aged children. Bisgaard H; Price MJ; Maden C; Olsen NA Chest; 2001 Dec; 120(6):1835-42. PubMed ID: 11742910 [TBL] [Abstract][Full Text] [Related]
16. Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study). Price JF; Weller PH Respir Med; 1995 May; 89(5):363-8. PubMed ID: 7638372 [TBL] [Abstract][Full Text] [Related]
17. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs. O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769 [TBL] [Abstract][Full Text] [Related]
18. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023). Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M; Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834 [TBL] [Abstract][Full Text] [Related]
19. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers. Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220 [TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma. Pearlman DS; Noonan MJ; Tashkin DP; Goldstein MF; Hamedani AG; Kellerman DJ; Schaberg A Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]